Literature DB >> 3135209

Pregnancy: a risk to initiation of leuprolide acetate during the luteal phase before controlled ovarian hyperstimulation.

P Serafini1, J Batzofin, J Kerin, R Marrs.   

Abstract

Mesh：

Substances：

Year:  1988        PMID： 3135209     DOI： 10.1016/s0015-0282(16)60090-0

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  2 in total

1.  The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles.

Authors:  J F Kerin
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

2.  Outcome of pregnancies inadvertently exposed to gonadotropin-releasing hormone analogues (GnRH-a) in early gestation.

Authors:  Y Gonen; M Dirnfeld; H Abramovici
Journal:  J Assist Reprod Genet       Date:  1993-08       Impact factor: 3.412
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.